author-photo

Mathilda Cominos

Canterbury Hospital

6

Papers

7

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

P3.02b-046 Afatinib Benefits Patients with Confirmed/Suspected EGFR Mutant NSCLC, Unsuitable for Chemotherapy (TIMELY Phase II Trial)

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Poster SessionP3.02b-046 Afatinib Benefits Patients with Confirmed/Suspected EGFR Mutant NSCLC, Unsuitable for Chemotherapy (TIMELY Phase II Trial): Topic: EGFR Clinical

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Palliative treatments for patients with inoperable gastroesophageal cancers

2006 International Journal of Palliative Nursing
Show All
- Source
- Cite
- Save
Citations (4)